Gridai Technologies Corp GRDX

$5.61 +0.12 (2.09%)

Valuation

Market cap: 39,970,000
Revenue TTM: $40,000
Net income TTM: $-6,390,000
PE ratio: 0.00
Forward PE: —
Profit margin: -15,975.00%
Debt to equity: 0.01

Trading

Volume: 254,600
Avg volume: 113,694
Day's range: $5.24 – $5.70
Shares out: 7,131,000
Stochastic %K: 94%
Beta: 1.69
Analysts: Hold
Price target: —

Price

Company profile

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kin...

Industry: Biotechnology
Sector: Healthcare
Website: https://www.grid-ai.com
Address: 91 George St, Edinburgh, United Kingdom

Latest news

2026-05-28T10:27:56.000Z · 5 months ago

GridAI files to sell 6.2M shares of common stock for holders

Apr 29, 2026, 1:30 PM EDT · 5 months ago

GridAI Technologies Corp. to Present at the Market Movers Investor Summit

Apr 28, 2026, 5:20 PM EDT · 5 months ago

GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing

2026-03-04T13:22:34.000Z · 7 months ago

GridAI identifies Amp Z as previously announced AI data center developer

Mar 4, 2026, 8:00 AM EST · 7 months ago

GridAI Technologies Corp. Identifies Amp Z as Previously Announced Stealth Hyperscaler AI Data Center Developer

Feb 4, 2026, 8:45 AM EST · 8 months ago

GridAI Technologies Corp. Appoints Veteran Energy Executive Tim Healy as Executive Chairman of Grid AI Corp.

2026-02-04T13:21:10.000Z · 8 months ago

GridAI appoints Healy as Executive Chairman of Grid AI Corp.

2026-01-26T13:41:35.000Z · 9 months ago

GridAI engages IBN for corporate communications strategy

Jan 14, 2026, 8:00 AM EST · 9 months ago

GridAI and the New Operating Reality of the Electric Grid

Jan 13, 2026, 8:20 AM EST · 9 months ago

GridAI's Role at the Center of Grid Intelligence Economics

Jan 12, 2026, 10:00 AM EST · 9 months ago

GridAI and the Financial Mechanics of Grid Intelligence

2025-12-04T15:06:28.000Z · 10 months ago

GridAI appoints Marshall Chapin as CEO of energy-orchestration subsidiary

Nov 28, 2025, 8:00 AM EST · 11 months ago

Entero Therapeutics, Inc. Announces Corporate Name Change to GridAI Technologies Corp. and New Ticker Symbol "GRDX"

Nov 19, 2025, 8:45 AM EST · 11 months ago

ENTO Subsidiary Grid AI Announces Letter of Intent with First Hyperscaler AI Data-Center Customer

Nov 13, 2025, 8:35 AM EST · 11 months ago

Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy

Nov 6, 2025, 8:45 AM EST · 11 months ago

Entero Subsidiary Grid AI Accelerates Expansion into Hyperscaler AI Data Center Market with Integration of LV Grid

Oct 30, 2025, 9:00 AM EDT · 12 months ago

Entero's Reinvention Gives the Grid, AI, and Investors Exactly What They're After: Power and Value (NASDAQ: ENTO)

Oct 30, 2025, 6:00 AM EDT · 12 months ago

Entero Regains Nasdaq Compliance With Grid AI Acquisition

Oct 16, 2025, 8:40 AM EDT · 1 year ago

Entero Therapeutics, Inc., Launches Grid AI Corp to Redefine How AI Infrastructure Connects to the Power Grid

Oct 14, 2025, 11:00 AM EDT · 1 year ago

From Biotech to Grid Tech, Entero Therapeutics Enters a $2.5 Billion Market Expected to Quadruple by 2033 (NASDAQ:ENTO)

Oct 14, 2025, 8:00 AM EDT · 1 year ago

Entero Therapeutics Steps Into the $2.5 Billion Grid-Edge Arena With Global-Scale Validation Behind It

Oct 1, 2025, 4:05 PM EDT · 1 year ago

ENTERO THERAPEUTICS (ENTO) Enters $100 Billion+ AI and Data Center Market with Acquisition of GRID AI

Oct 1, 2025, 8:30 AM EDT · 1 year ago

ENTERO THERAPEUTICS (ENTO) Acquires 100% of GRID AI, a Grid-Edge AI Platform Optimizing Next-Gen Power Demand

Aug 14, 2025, 9:15 AM EDT · 1 year ago

Entero Therapeutics, Inc. Announces Reverse Stock Split

Aug 11, 2025, 7:30 AM EDT · 1 year ago

Entero Therapeutics, Inc. Announces $3.0 Million Private Placement Priced at the Market Under Nasdaq Rules

Jun 13, 2025, 10:46 AM EDT · 1 year ago

FluroTech Ltd. Announces Change in Directors

MMA

Mar 24, 2025, 10:51 PM EDT · 1 year ago

Entero Therapeutics Announces Signing of Rescission Agreement with ImmunogenX, LLC

Feb 14, 2025, 4:00 PM EST · 1 year ago

Entero Therapeutics Appoints Richard Paolone as CEO

Feb 7, 2025, 3:22 PM EST · 1 year ago

Entero Therapeutics Secures $2 Million Revolving Loan; Appoints Three New Board Members

Nov 15, 2024, 8:00 AM EST · 1 year ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PULM and ENTO on Behalf of Shareholders

PULM

Nov 14, 2024, 6:50 PM EST · 1 year ago

ENTERO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Entero Therapeutics, Inc. - ENTO

Nov 13, 2024, 7:00 AM EST · 1 year ago

Entero Therapeutics Announces Proposed Reverse Merger with Journey Therapeutics, A Clinical Stage, First-in-Class, Next-Generation ADC-rivalling Nano-immunoconjugates Biopharmaceutical Company

Oct 8, 2024, 5:00 AM EDT · 2 years ago

Virometix appoints Christina Ackermann as Chair and Tim Ramdeen as member of the Board

OCS ONCO VRNA

Aug 23, 2024, 5:00 PM EDT · 2 years ago

Entero Therapeutics, Inc. Receives Nasdaq Notification Regarding Delayed Form 10-Q

Jul 31, 2024, 7:00 AM EDT · 2 years ago

Entero Therapeutics' Chairman and CEO James Sapirstein Provides Business Update with Focus on Latiglutenase Development Program

Jun 27, 2024, 6:00 AM EDT · 2 years ago

Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease

May 22, 2024, 7:00 AM EDT · 2 years ago

Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention

May 20, 2024, 7:00 AM EDT · 2 years ago

Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference

Stocktwits

VaporWaves Oct 25, 6:19 PM

Everyone should put ICMB on their watch list. ICMB $3.44 stock sitting under a dollar seems like a no brainer buy. ICMB a good opportunity for us to make some money on! $GRDX $HUIZ $MSS $SKYA :)).

0 replies

grncandle Oct 23, 9:15 PM

$GRDX Huge9

0 replies

LewisIntegrated Oct 23, 5:56 PM

If you’ve ever wanted to catch a short squeeze early instead of watching it rip after the fact, this group is built for that. Sharing momentum, setups, and what we’re watching as it develops, not when it’s already gone. Click link and join for Free ⭐ $TRON $NTHI $GRDX

0 replies